Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Diletta Barone
Observed names:
Barone, Diletta,
D. Barone
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic
Observed institutions:
Università Cattolica del Sacro Cuore,
Memorial Sloan Kettering Cancer Center,
Agostino Gemelli University Polyclinic,
IRCCS Ospedale San Raffaele,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0003-1666-5210
Observed ORCID:
0000-0003-1666-5210
OpenAlex ID:
A5040267811
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis
2024
·
Luca Mastrantoni
, Marta Chiaravalli
, et al.
·
The Lancet Oncology
·
73
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial
2018
·
Michele Reni
, Silvia Zanon
, et al.
·
The Lancet. Gastroenterology & hepatology
·
73
Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma
2020
·
Eileen M. O'Reilly
, Diletta Barone
, et al.
·
European Journal of Cancer
·
36
Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer
2022
·
Alessio Stefani
, Geny Piro
, et al.
·
Frontiers in Oncology
·
18
PDF
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC)
2023
·
Emanuele Vita
, Alessio Stefani
, et al.
·
Cancer Immunology Immunotherapy
·
13
PDF
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK‐positive advanced non–small cell lung cancer
2024
·
Emanuele Vita
, Federico Monaca
, et al.
·
Cancer
·
8
PDF
GATA6 expression in advanced pancreatic ductal adenocarcinoma (PDAC) as a prognostic and predictive biomarker in the Canadian COMPASS trial and the Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
2024
·
Ronan Andrew Mc Laughlin
, Lisa Salvatore
, et al.
·
Journal of Clinical Oncology
·
4
Fertility and sexuality in early-onset colorectal cancer patients: a monocentric survey
2025
·
A. Spring
, M.A. Calegari
, et al.
·
ESMO Gastrointestinal Oncology
·
2
PDF
The impact of second-line treatment after fist-line cisplatin plus gemcitabine in advanced biliary tract cancers: A mono-institutional retrospective study.
2022
·
Marta Chiaravalli
, Maria Bensi
, et al.
·
Journal of Clinical Oncology
·
2
Epidemiological and clinicopathological features of patients (pts) with early- (EOPC) and late-onset pancreatic cancer (LOPC): A mono-institutional retrospective analysis.
2023
·
Maria Bensi
, Lisa Salvatore
, et al.
·
Journal of Clinical Oncology
·
1
P-275 FOLFOX versus FOLFIRI as second-line treatment after cisplatin-gemcitabine in patients with advanced biliary tract cancers
2023
·
F. Nichetti
, M. Rizzato
, et al.
·
Annals of Oncology
·
1
PDF
DNA damage repair (DDR) germline mutations (GMs) in pancreatic ductal adenocarcinoma (PDAC): A mono-institutional retrospective study.
2022
·
Maria Bensi
, Angelo Minucci
, et al.
·
Journal of Clinical Oncology
·
1
P-74 The impact of first-line chemotherapy in elderly patients with advanced pancreatic cancer: A mono-institutional retrospective study
2021
·
M. Maratta
, M. Chiaravalli
, et al.
·
Annals of Oncology
·
1
PDF
AP1-mediated reprogramming of EGFR expression triggers resistance to BLU-667 and LOXO-292 in RET-rearranged tumors
2025
·
Daniela Esposito
, Claudia Maria Ascione
, et al.
·
Journal of Experimental & Clinical Cancer Research
PDF
p53 pathway genes' mutations as prognostic factors in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): A single center study.
2025
·
Giovanni Trovato
, Diletta Barone
, et al.
·
Journal of Clinical Oncology
PDF
136P Fertility and sexuality in early onset-colorectal cancer (EO-CRC) patients (pts): A monocentric survey
2024
·
A. Spring
, D. Barone
, et al.
·
Annals of Oncology
PDF
356P Late-onset pancreatic cancer (LOPC) patients (pts) treated at an Italian center: A real-word analysis from the Gemelli GENERATOR experience
2024
·
A. Cosmai
, G. Trovato
, et al.
·
Annals of Oncology
PDF
348P Early-onset pancreatic cancer (EOPC) patients (pts) treated at an Italian third level referral center: A real-word artificial-intelligence (AI) analysis from the Gemelli Generator experience
2024
·
L. DiFrancesco
, G. Trovato
, et al.
·
Annals of Oncology
357P Single-center analysis of DNA damage repair (DDR) germline mutations (GM) in patients (pts) with advanced pancreatic ductal adenocarcinoma (aPDAC)
2024
·
G. Trovato
, M. Bensi
, et al.
·
Annals of Oncology
Second-line chemotherapy in elderly patients with advanced pancreatic cancer: A mono-institutional retrospective experience.
2024
·
Giovanni Trovato
, Maria Bensi
, et al.
·
Journal of Clinical Oncology
PDF
2062P The psychological distress (PsyD) evaluation in pancreatic cancer (PC) patients (pts): A mono-institutional analysis
2023
·
M. Bensi
, D. Belella
, et al.
·
Annals of Oncology
PDF
1679P Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: A systematic review and network meta-analysis
2023
·
L. Mastrantoni
, V. Beccia
, et al.
·
Annals of Oncology
PDF
P-110 Epidemiological and clinicopathological features of early- (EOPC) and late-onset pancreatic cancer (LOPC) patients (pts): A mono-institutional retrospective analysis
2023
·
M. Bensi
, L. Salvatore
, et al.
·
Annals of Oncology
PDF
Adjuvant therapy (AT) in patients (pts) with radically resected ampullary adenocarcinoma (AA): A monocentric retrospective analysis.
2022
·
Maria Grazia Maratta
, Maria Bensi
, et al.
·
Journal of Clinical Oncology
P-155 Adjuvant therapy (AT) in patients (pts) with radically resected ampullary adenocarcinoma (AA): A monocentric retrospective analysis
2022
·
D. Barone
, M. Maratta
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
29
Citation count:
233
H-index:
6
I10-index:
5
Year
Topic
Type